Pharmazeutische Dosierformen
European patent · EP2343071 · In force
Register entry
- Publication number
- EP2343071
- Application number
- EP11156997
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Aug 24, 2007
- Published
- Jul 13, 2011
- Granted
- Mar 20, 2013
- Protection ends at the latest
- Aug 23, 2027
- Next annual fee due
- Aug 31, 2027
- IPC classes
- A61K 31/485 (2006.01)A61K 9/22 (2006.01)A61K 9/32 (2006.01)
- Priority
- US 840244 P 25.08.2006
- Divided from
- EP10192627
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 21, 2026
Next annual fee due on
- Next annual fee due on
- 31.08.2026 → 31.08.2027
Published in Swissreg on 21.10.2026
- Sep 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.08.2025 → 31.08.2026
Published in Swissreg on 01.09.2025
- Sep 1, 2024
Next annual fee due on
- Next annual fee due on
- 31.08.2024 → 31.08.2025
Published in Swissreg on 01.09.2024
- Sep 1, 2023
Change
Published in Swissreg on 01.09.2023
- Sep 1, 2022
Change
Published in Swissreg on 01.09.2022
- May 2, 2013
Agent entered
- Representative
- BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3000 Bern 25
Published in Swissreg on 02.05.2013
- Mar 20, 2013
Granted
Published in Swissreg on 20.03.2013
Parties
Inventor
Furlong, PA 18925, US
Princeton, NJ 08540, US
Yonkers, NY 10704, US
Basking Ridge, NJ 07920, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.